[quote alias=Kin id=9074251 date=201601062137]
THE ALLIANCE FOR REGENERATIVE MEDICINE ANNOUNCES 2016 REGEN MED AND ADVANCED THERAPIES STATE OF THE INDUSTRY BRIEFING
WASHINGTON, DC--(Marketwired - Jan 6, 2016) - The Alliance for Regenerative Medicine (ARM), the international organization representing the gene therapy, cell therapy and tissue engineering sectors, announced its 2016 Regen Med & Advanced Therapies State of the Industry briefing will take place January 11, 2016 in San Francisco.
The briefing will provide a comprehensive industry update detailing key sector trends and metrics, anticipated clinical data events, recent advances and the outlook for the coming year.
The briefing will serve as a top-level gathering of more than 300 key stakeholders from the cell therapy, gene therapy and immuno-oncology fields, featuring sessions with industry experts, CEOs and senior executives from leading companies in the sector.
Program Agenda:
8:00 - 8:20am Introduction & Industry Update
Morrie Ruffin, Managing Director, Alliance for Regenerative Medicine
Edward Lanphier, Chairman, Alliance for Regenerative Medicine; President & CEO, Sangamo BioSciences
8:20 - 9:05am 2016 Sector Forecast: Upcoming Clinical Data Events
Jason Kolbert, Head of Healthcare Research & Senior Managing Director, Maxim Group (moderator)
Eduardo Bravo, CEO, TiGenix
Silviu Itescu, Managing Director & CEO, Mesoblast
Sven Kili, VP & Head of Gene Therapy Development, GlaxoSmithKline
Jeffrey Walsh, COO, bluebird bio
Sue Washer, President & CEO, AGTC
9:05 - 9:50am The Promise of Regenerative Medicine & Advanced Therapies in Oncology
[/quote
Jammer dat $QURE niet mee mag doen en $blue weer wel. Tigenix is wel van de partij.